Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase NA 3Phase 4 3Phase 1 2Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Vomiting 5Nausea 2Solid Tumours 1Neoplasms 1Breast Neoplasms 1

Interventions

casopitant 2Granisetron 2Cyclophosphamide 2fosaprepitant 1Tablets 1Methadone 1Injections, Intravenous 1Dronabinol 1Docetaxel 1Cannabidiol 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Nausea × Granisetron × Clear all
NCT01649258 2017-11-17

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

University of Southern California

Phase 1 Terminated
29 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

NCT02563951 2016-01-08

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers

Maxinase Life Sciences Ltd.

Phase 1 Completed
50 enrolled

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡